Glaukos Return on Tangible Equity 2014-2025 | GKOS
Current and historical return on tangible equity values for Glaukos (GKOS) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Glaukos Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $-0.12B | $0.44B | -32.35% |
| 2024-12-31 | $-0.15B | $0.44B | -49.16% |
| 2024-09-30 | $-0.15B | $0.33B | -68.81% |
| 2024-06-30 | $-0.16B | $0.32B | -96.22% |
| 2024-03-31 | $-0.14B | $0.10B | -121.29% |
| 2023-12-31 | $-0.14B | $0.11B | -107.36% |
| 2023-09-30 | $-0.13B | $0.12B | -94.51% |
| 2023-06-30 | $-0.13B | $0.13B | -85.81% |
| 2023-03-31 | $-0.14B | $0.14B | -87.36% |
| 2022-12-31 | $-0.10B | $0.16B | -56.74% |
| 2022-09-30 | $-0.09B | $0.17B | -49.39% |
| 2022-06-30 | $-0.06B | $0.18B | -29.80% |
| 2022-03-31 | $-0.03B | $0.21B | -14.70% |
| 2021-12-31 | $-0.05B | $0.19B | -26.89% |
| 2021-09-30 | $-0.04B | $0.20B | -19.36% |
| 2021-06-30 | $-0.06B | $0.17B | -29.23% |
| 2021-03-31 | $-0.08B | $0.17B | -37.99% |
| 2020-12-31 | $-0.12B | $0.24B | -53.72% |
| 2020-09-30 | $-0.07B | $0.23B | -33.11% |
| 2020-06-30 | $-0.07B | $0.23B | -33.81% |
| 2020-03-31 | $-0.04B | $0.20B | -18.45% |
| 2019-12-31 | $0.02B | $0.23B | 8.12% |
| 2019-09-30 | $-0.02B | $0.19B | -10.31% |
| 2019-06-30 | $-0.01B | $0.19B | -6.76% |
| 2019-03-31 | $-0.01B | $0.19B | -6.58% |
| 2018-12-31 | $-0.01B | $0.17B | -8.32% |
| 2018-09-30 | $-0.01B | $0.16B | -9.56% |
| 2018-06-30 | $-0.01B | $0.15B | -4.36% |
| 2018-03-31 | $0.00B | $0.14B | -3.05% |
| 2017-12-31 | $0.00B | $0.14B | 0.00% |
| 2017-09-30 | $0.00B | $0.13B | -0.84% |
| 2017-06-30 | $0.00B | $0.12B | -0.88% |
| 2017-03-31 | $0.00B | $0.12B | 3.74% |
| 2016-12-31 | $0.00B | $0.11B | 4.00% |
| 2016-09-30 | $0.00B | $0.10B | 2.14% |
| 2016-06-30 | $0.00B | $0.10B | -1.13% |
| 2016-03-31 | $-0.04B | $0.09B | -41.06% |
| 2015-12-31 | $-0.04B | $0.09B | -62.98% |
| 2015-09-30 | $-0.04B | $0.08B | -120.30% |
| 2015-06-30 | $-0.04B | $0.08B | -318.37% |
| 2015-03-31 | $-0.01B | $-0.02B | 105.88% |
| 2014-12-31 | $-0.01B | $-0.02B | 282.35% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.374B | $0.383B |
| Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $180.170B | 21.80 |
| Intuitive Surgical (ISRG) | United States | $179.421B | 74.37 |
| Edwards Lifesciences (EW) | United States | $47.608B | 31.58 |
| IDEXX Laboratories (IDXX) | United States | $46.009B | 52.87 |
| Alcon (ALC) | Switzerland | $43.988B | 29.73 |
| DexCom (DXCM) | United States | $34.921B | 52.39 |
| IQVIA Holdings (IQV) | United States | $32.562B | 18.40 |
| Mettler-Toledo (MTD) | United States | $26.309B | 31.29 |
| STERIS (STE) | Ireland | $22.554B | 24.84 |
| Waters (WAT) | United States | $17.797B | 25.11 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.385B | 0.00 |
| Hologic (HOLX) | United States | $14.480B | 15.66 |
| Sysmex ADR (SSMXY) | Japan | $10.386B | 29.46 |
| Penumbra (PEN) | United States | $9.845B | 72.42 |
| Masimo (MASI) | United States | $8.459B | 31.20 |
| Globus Medical (GMED) | United States | $7.236B | 17.24 |
| Teleflex (TFX) | United States | $5.034B | 8.31 |
| Integer Holdings (ITGR) | United States | $3.810B | 19.01 |
| TransMedics (TMDX) | United States | $3.643B | 55.80 |
| PROCEPT BioRobotics (PRCT) | United States | $2.841B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.400B | 14.29 |
| Nihon Kohden (NHNKY) | Japan | $1.956B | 22.43 |
| Elekta AB (EKTAY) | Sweden | $1.903B | 17.10 |
| Veracyte (VCYT) | United States | $1.877B | 26.34 |
| Alphatec Holdings (ATEC) | United States | $1.568B | 0.00 |
| Artivion (AORT) | United States | $1.348B | 126.28 |
| Tandem Diabetes Care (TNDM) | United States | $1.110B | 0.00 |
| OPKO Health (OPK) | United States | $1.063B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.991B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.961B | 5.11 |
| SiBone (SIBN) | United States | $0.759B | 0.00 |
| IRadimed (IRMD) | United States | $0.742B | 37.66 |
| Beta Bionics (BBNX) | United States | $0.727B | 0.00 |
| AxoGen (AXGN) | United States | $0.601B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.540B | 8.40 |
| OrthoPediatrics (KIDS) | United States | $0.527B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.495B | 10.66 |
| Pacific Biosciences Of California (PACB) | United States | $0.447B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.445B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.434B | 10.08 |
| Delcath Systems (DCTH) | United States | $0.381B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.364B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.348B | 0.00 |
| RxSight (RXST) | United States | $0.324B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.298B | 0.00 |
| Neuronetics (STIM) | United States | $0.294B | 0.00 |
| NeuroPace (NPCE) | United States | $0.287B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.246B | 0.00 |
| 908 Devices (MASS) | United States | $0.244B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.236B | 14.30 |
| CVRx (CVRX) | United States | $0.215B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.200B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.178B | 0.00 |
| Inogen (INGN) | United States | $0.176B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.166B | 0.00 |
| LENSAR (LNSR) | United States | $0.156B | 0.00 |
| Accuray (ARAY) | United States | $0.151B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.123B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.120B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.113B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.109B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.094B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.087B | 52.90 |
| EnVVeno Medical (NVNO) | United States | $0.085B | 0.00 |
| Hyperfine (HYPR) | United States | $0.079B | 0.00 |
| InspireMD (NSPR) | United States | $0.073B | 0.00 |
| Spectral AI (MDAI) | United States | $0.062B | 0.00 |
| Positron (POSC) | United States | $0.061B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.055B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.051B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.050B | 20.33 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.026B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.014B | 0.00 | |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 14.74 |